Ján Zelenay, Viliam Fridrich
Aim: The aim of the treatment of isolated valvular pulmonic stenosis is to remove or reduce severe stenosis of the pulmonic valve without using surgical intervention. Patients and methods: Our retrospective study involved 25 patients of average age of 42.5 years (mean age 42.5 years). In 16 women (64 %) and 9 men (36 %) anatomical, morphological, haemodynamics and functioal success of percutaneous translumonal pulmonal valvuloplasty (PTPV) was evaluated. Narrowing of the pulmonal valve with peak systolic gradient (PSG) the right ventricle-pulmonal artery over 50 mmHg with the index of systolic intraventricular pressures over 0.5 and the index of the pulmonal valve surface less than 0.79 cm2/m2, were considered significant. Before PTPV the whole set of patients was classified (according to functional classification NYHA) as NYHA 3.3. Result: Before PTPV the average PSG was 106.5 mmHg. After PTPV PSG was reduced to 38.4 mmHg (p < 0.001). The average ISVKT before intervention was 1.12, after intervention 0.44 (p < 0.0001). The average IPPCH was 0.44 cm2/m2. After PTPV an increase to 0.82 cm2/m2. In long term follow-up 84 % of patients benefit from the treatment (average functional classification NYHA 2.0) Conclusion: Percutaneous transluminal pulmonal valvuloplasty is, in the treatment of isolated valvular pulmonic stenosis, the method of the first and most definite choice for very good therapeutic results, lower costs and lower invasiveness.